Sign In

Deepankar Roy

Investor Relations

Deepankar Roy is a seasoned investor relations professional with expertise in biotech equity, entrepreneurship, and research biology.

With a Ph.D. in Biochemistry and Molecular Biology from the University of Southern California, an MS in Genetics, and a BS Honors in Zoology from the University of Delhi, Deepankar has a strong educational background.

Throughout his career, he has held key roles in investor relations and corporate communications at notable biotech companies like Keros Therapeutics, Arcturus Therapeutics, and Travere Therapeutics.

He has also demonstrated leadership in business and R&D operations at early-stage life sciences entities and has expertise in business development, due diligence, market analysis, and partnership management.

Having worked in life sciences equity research, venture capital, and investment banking, Deepankar is well-versed in diverse aspects of the industry.

His experience spans disciplines such as oncology, immunology, drug development, and process biology, reflecting a broad knowledge base within the life sciences sector.

In addition to his corporate roles, Deepankar has been involved in various ventures and organizations, including Wildflower Biopharma, Murrieta Genomics, Brookline Capital Markets, Biotech Alliances International, Venomyx Therapeutics, Forentis Fund, Larix Bioscience, Genentech, and as a Postdoctoral Fellow at Genentech.

Passionate about life sciences business and investments, Deepankar is open to mentorship, learning opportunities, and collaborations within the industry.

Deepankar Roy
Add to my network

Location

San Diego, California, United States